Explore health content from A to Z.
I need information about...
The following are among the breakthroughs that we are achieving not for the sake of research, but for yours.
Two immune system proteins could be the culprit behind many lupus patients' resistance to widely used steroid treatments, scientists with the Baylor Research Institute (BRI) in Dallas announced today. It is estimated that more than 5 million people suffer from lupus worldwide. Read more
People with Type 1 diabetes may gain extraordinary benefits if an experimental project with pancreatic cell transplantation proves successful. We're transplanting islet cells in an effort to prevent the serious effects of this disease, which include heart disease, blindness, kidney damage, and premature death. The early results look promising.
Malignant melanoma is increasing worldwide at a rate surpassed only by lung cancer. And once it invades the vital organs, it's virtually incurable. We have discovered that a vaccine made from a patient's dendritic cells may stimulate the immune system and cause the cancer's regression. Such research could bring a whole new dimension to life-saving treatments.
In the U.S., the second leading cause of cancer deaths is colorectal cancer, a silent killer whose symptoms are often overlooked. We're investigating the role of certain viruses in the cause of this disease, as well as vaccines that could prevent it. We're also engaged in clinical trials to prevent polyps.
Heart disease, the number one cause of death, takes someone's life every 33 seconds in the U.S. We're studying new drugs with potential life-saving effects, from lowering cholesterol levels and blood pressure to increasing blood flow to the legs and reducing arterial inflammation. With 80 ongoing studies, we've invested significant time and resources in cardiovascular research to improve and extend lives.
Copyright © 2013 Baylor Health Care System All Rights Reserved. |
3500 Gaston Avenue, Dallas, TX 75246-2017 | 1.800.4BAYLOR